Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016)

Clinical trial NCT00092495 · COMPLETED

Trial details

NCT number: NCT00092495
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cervical Cancer Genital Warts

Start date: 2002-12-01
Primary completion: 2004-09-01
Enrollment: 3055

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.